Sweet succession: Gonzalez, patent thickets and his triumph over biosimilars
Podcast: BioSpacePublished On: Wed Feb 28 2024
Description: This week Lori, Greg and Tyler discuss AbbVie: how longtime CEO Richard Gonzalez navigated Humira's LOE, his victorious retirement announcement, and the future of biosimilars. Also discussed: Earlybird Health's $186m VC fund; and definitely not the IRA.
The note was deleted
The note was saved
Your message was sent